12:00 AM
 | 
Oct 08, 2012
 |  BC Week In Review  |  Company News  |  Deals

Advanced Immune Therapeutics, Quest Pharma deal

Quest acquired all of Advanced Immune's assets related to its AllergoOncology technology, including two pending U.S. patent applications and preclinical candidates for breast and prostate cancer. The technology, which was discovered in collaboration...

Read the full 144 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >